Hint mode is switched on Switch off
For swift navigation between sections

Day One Biopharmaceuticals

PDF download

Choose all Reset all
Download Cancel
Organization name
Day One Biopharmaceuticals, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Day One Biopharmaceuticals, Inc. operates as a biotechnology company. The Company focuses on science research, technologies, therapeutic development, and makes medicines for the treatment and diagnosis of cancer. Day One Biopharmaceuticals serves patients, healthcare professionals, pharmaceutical, and biotechnology industries in the United States.

Awards

News

22/04/2026 Day One Biopharmaceuticals: Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, , Item 5.01 And Item 5.03 Are Incorporated Herein By Reference, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
06/03/2026 Day One Biopharmaceuticals: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
02/03/2026 Day One Biopharmaceuticals: Regulation Fd Disclosure, Financial Statements And Exhibits
06/01/2026 Day One Biopharmaceuticals: Of The Original Report To Include The Audited Consolidated Financial Statements Of Target (as Defined In The Original Report) As Of And For The Years Ended December 31, 2024 And December 31, 2023 And To Include The Unaudited Interim Condensed Consolidated Financial Statements Of Target As Of And For The Three And Nine Months Ended September 30, 2025; And (ii) Update The Information In Item 9.01(b) Of The Original Report To Include The Unaudited Pro Forma Condensed Combined Financial Information Of Parent And Target (collectively, The "
06/01/2026 Day One Biopharmaceuticals: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001845337
  • EIN
    83-2415215
Registration is required to get access.